StockNews.com Begins Coverage on CASI Pharmaceuticals (NASDAQ:CASI)

StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report released on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. CASI Pharmaceuticals Stock Performance NASDAQ CASI opened at $3.61 on Thursday. CASI Pharmaceuticals has a fifty-two week low of $1.85 and a fifty-two week […]

Related Keywords

United States , ,Renaissance Technologies ,Susquehanna International Group ,Pharmaceuticals Daily ,Citigroup Inc ,Pharmaceuticals Stock Performance ,Pharmaceuticals Inc ,Virtu Financial ,Free Report ,Get Free Report ,International Group ,Casi Pharmaceuticals ,Nasdaq Casi ,Casi ,Medical ,Initiated Coverage ,Stocknews Com ,